Integrin Inhibitor Suppresses Bevacizumab-Induced Glioma Invasion()()

Glioblastoma is known to secrete high levels of vascular endothelial growth factor (VEGF), and clinical studies with bevacizumab, a monoclonal antibody to VEGF, have demonstrated convincing therapeutic benefits in glioblastoma patients. However, its induction of invasive proliferation has also been...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Joji, Onishi, Manabu, Kurozumi, Kazuhiko, Ichikawa, Tomotsugu, Fujii, Kentaro, Shimazu, Yosuke, Oka, Tetsuo, Date, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101347/
https://www.ncbi.nlm.nih.gov/pubmed/24704537
http://dx.doi.org/10.1016/j.tranon.2014.02.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101347/
https://www.ncbi.nlm.nih.gov/pubmed/24704537
http://dx.doi.org/10.1016/j.tranon.2014.02.016

Ejemplares similares